Cerebroretinal Microangiopathy with Calcifications and Cysts (Coats plus syndrome) via the CTC1 Gene
Summary and Pricing ![](img/next-arrow.png)
Test Method
Exome Sequencing with CNV DetectionTest Code | Test Copy Genes | Test CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
8043 | CTC1 | 81479 | 81479,81479 | $990 | Order Options and Pricing |
Pricing Comments
Our favored testing approach is exome based NextGen sequencing with CNV analysis. This will allow cost effective reflexing to PGxome or other exome based tests. However, if full gene Sanger sequencing is desired for STAT turnaround time, insurance, or other reasons, please see link below for Test Code, pricing, and turnaround time information.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).
Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).
The Sanger Sequencing method for this test is NY State approved.
For Sanger Sequencing click here.Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics ![](img/next-arrow.png)
Clinical Features
Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) is a multisystem disorder particularly affecting the eye, brain, bone and gastrointestinal tract. It is also known as Coats plus syndrome due to the presence of presence of bilateral retinal telangiectasia and exudates (Coats disease), cerebral calcification, leukoencephalopathy, slow pre- and post-natal linear growth and defects of bone marrow and integument (Crow et al. 2004; Linnankivi et al. 2006).
Genetics
CRMCC is an autosomal recessive disorder, which is caused by pathogenic variants in CTC1 gene. CTC protein is a member of the CTC1–STN1–TEN1 (CST) complex, which is critical for telomere replication. This explains the presence of critically shortened telomeres in CRMCC patients, and suggests that telomere dysfunction plays a key role in CRMCC pathogenesis (Gu and Chang 2013). So far, over 25 causative variants (missense, nonsense, splicing, small deletions and insertions) have been reported to be causative in CTC1 (Human Gene Mutation Database).
Clinical Sensitivity - Sequencing with CNV PGxome
A mutation screening in 10 CRMCC patients found that all patients were compound heterozygous for CTC1 pathogenic variants (Anderson et al. 2012). In another study in 15 CRMCC-Affected Individuals, 13 patients were compound heterozygous for CTC1 pathogenic variants (Polvi et al. 2012). These studies suggest that the clinical sensitivity is high. Analytical sensitivity should be high as well because all the reported CTC1 causative variants are detectable by sequencing.
Testing Strategy
This test provides full coverage of all coding exons of the CTC1 gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).
Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).
Indications for Test
All patients with symptoms suggestive of Coats plus syndrome. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in CTC1.
All patients with symptoms suggestive of Coats plus syndrome. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in CTC1.
Gene
Official Gene Symbol | OMIM ID |
---|---|
CTC1 | 613129 |
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Disease
Name | Inheritance | OMIM ID |
---|---|---|
Cerebroretinal Microangiopathy with Calcifications and Cysts | AR | 612199 |
Citations ![](img/next-arrow.png)
- Anderson BH. et al. 2012. Nature genetics. 44: 338-42. PubMed ID: 22267198
- Crow YJ. et al. 2004. Neuropediatrics. 35: 10-9. PubMed ID: 15002047
- Gu P., Chang S. 2013. Aging cell. 12: 1100-9. PubMed ID: 23869908
- Human Gene Mutation Database (Bio-base).
- Linnankivi T. et al. 2006. Neurology. 67: 1437-43. PubMed ID: 16943371
- Polvi A. et al. 2012. American journal of human genetics. 90: 540-9. PubMed ID: 22387016
Ordering/Specimens ![](img/next-arrow.png)
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
PGxome (Exome) Sequencing Panel
PGnome (Genome) Sequencing Panel
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.